Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Flourish Pediatric Esophageal Atresia Device Post-Approval Study (Flourish)

NCT03615495 is registered in ClinicalTrials.gov with Cook Research Incorporated as lead sponsor.

NCT NCT03615495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03615495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Flourish Pediatric Esophageal Atresia Device Post-Approval Study (Flourish)
Lead sponsor
Cook Research Incorporated
Phase
Observational
Overall status
Completed
Start date
November 5, 2018
Completion date
November 27, 2023
Enrollment
21 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

digestive system abnormalities, esophageal atresia, esophageal disorders congenital